Investasi
Fitur
BiayaKeamanan
Akademi
Lainnya
Pluang+

Bandingkan Harga & Kinerja Marga Abhinaya Abadi Tbk. (MABA) vs Organon Pharma Indonesia Tbk. (SCPI)

Marga Abhinaya Abadi Tbk.Trading
Organon Pharma Indonesia Tbk.Trading

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan Marga Abhinaya Abadi Tbk. dan Organon Pharma Indonesia Tbk.: Marga Abhinaya Abadi Tbk. diperdagangkan di Rp50 (kapitalisasi pasar 768,26 M), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Marga Abhinaya Abadi Tbk. jauh lebih besar — sekitar 7,4× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.

MABASCPI
Kapitalisasi Pasar
768,26 M104,4 M

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

SCPI
Lihat detail

Tentang Marga Abhinaya Abadi Tbk.

PT Marga Abhinaya Abadi Tbk (the Company) formerly PT Lintas Insana Wisesa was established based on the Deed No. 01 dated November 11, 2009 of Imam Wahyudi, SH Notary in Tangerang.

Selengkapnya di halaman MABA

Tentang Organon Pharma Indonesia Tbk.

PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.

Selengkapnya di halaman SCPI